Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients

Zhou, S; Khanal, S; Zhang, HJ

Zhang, HJ (reprint author), Southeast Univ, Med Sch, Zhongda Hosp, Dept Oncol, 87 Dingjiaqiao Rd, Nanjing 210009, Jiangsu, Peoples R China.

THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2019; 15 (): 211

Abstract

Purpose: The aim of this study was to evaluate the risk of immune-related adverse events (irAEs) among cancer patients receiving nivolumab-plus-ipilim......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索